Triplet Therapy, Transplantation, and Maintenance until Progression in MyelomaPaul G. Richardson, Irene M. Ghobrial, Edward N. Libby et al.|New England Journal of Medicine|2022Cited by 457
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II TrialPhilippe Armand, Leo I. Gordon, Arnon Nagler et al.|Journal of Clinical Oncology|2013Cited by 439
Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone diseaseSonia Vallet, Noopur Raje, Siddhartha Mukherjee et al.|Proceedings of the National Academy of Sciences|2010Cited by 235
Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammationMary Speir, Ben A. Croker, Cameron J. Nowell et al.|Nature Immunology|2019Cited by 58